[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370251-105":3,"detail-sidebar-cat-0-en-105":84,"doc-detail-370251-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":77,"head_meta":79,"extra_data":81,"updated_unix":83},105,"en","changes-of-diamine-oxidase-and-d-lactate-in-human-breast-and-gynecologic-cancers-after-chemotherapy","Changes of diamine oxidase and D-lactate in human breast and gynecologic cancers after chemotherapy","","Study examines how chemotherapy affects diamine oxidase (DAO) and D-lactate in patients with breast and gynecologic malignancies and how these markers relate to intestinal barrier function and clinical status. Patients receiving chemotherapy from January 2020 to December 2023 provided blood samples before treatment, within 3 days after chemotherapy, and before the next course. Plasma DAO and D-lactate were measured by ELISA, while albumin (ALB), prealbumin (PAB), and gastrointestinal symptoms were recorded. After chemotherapy, both markers rose significantly versus baseline (P \u003C .05), and higher DAO and D-lactate before subsequent cycles were linked to diarrhea, anorexia, vomiting, and nausea. Monitoring levels may help evaluate gastrointestinal dysfunction and nutritional status.",{"@graph":14,"@context":76},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/changes-of-diamine-oxidase-and-d-lactate-in-human-breast-and-gynecologic-cancers-after-chemotherapy/370251/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/changes-of-diamine-oxidase-and-d-lactate-in-human-breast-and-gynecologic-cancers-after-chemotherapy/370251.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":26},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68,72],{"name":59,"@type":60,"acceptedAnswer":61},"What is the main objective of this study?","Question",{"text":62,"@type":63},"To evaluate changes in serum/plasma diamine oxidase (DAO) and D-lactate after chemotherapy and assess their clinical significance for intestinal barrier function, gastrointestinal dysfunction, and nutritional status.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How were DAO and D-lactate measured, and when were blood samples collected?",{"text":67,"@type":63},"Plasma DAO and D-lactate levels were measured by ELISA. Blood was collected before chemotherapy, within 3 days after chemotherapy, and before the next chemotherapy course.",{"name":69,"@type":60,"acceptedAnswer":70},"What did the study find about DAO and D-lactate after chemotherapy?",{"text":71,"@type":63},"After chemotherapy, serum DAO and D-lactate levels were significantly higher than pre-chemotherapy levels (P \u003C .05). Levels before the next course were higher than baseline but did not reach statistical significance (P > .05).",{"name":73,"@type":60,"acceptedAnswer":74},"How did DAO and D-lactate relate to chemotherapy-related gastrointestinal symptoms and nutrition?",{"text":75,"@type":63},"Higher DAO before chemotherapy was observed in patients who developed diarrhea and anorexia after chemotherapy, and higher D-lactate was seen in those who developed vomiting, diarrhea, and nausea. The study also assessed nutritional markers (ALB and PAB) and suggests monitoring DAO/D-lactate to reflect gastrointestinal dysfunction and nutritional status.","https://schema.org",{"og:url":32,"og:type":78,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":80,"canonical":32},"index,follow",{"doc_id":82,"site_id":7},370251,1790187611,{"code":4,"msg":85,"data":86},"success",[87,91,95,99,104,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":96,"show_sort_weight":97,"slug":98},"Exam",70,"exam",{"id":100,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},5,"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":100,"slug":133},19,"General","general",{"code":4,"msg":85,"data":135},{"doc_id":82,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":26,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":33,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":83,"read_time":127,"preview_page_count":33,"preview_urls":147},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","®  \n Observational Study   \nChanges of diamine oxidase and D-lactate inhuman breast and gynecologic cancers after chemotherapy  \nLixia Hu, MDa ,* , Fanliang Kong, MDa , Qianqian Yuan, MDa , Mengqin Huang, MDa , Yong Huang, MDa  \n| Abstract\u003Cbr>This study investigates the changes in diamine oxidase (DAO) and D-lactate levels in cancer patients undergoing chemotherapy and their clinical significance in evaluating intestinal barrier function. Breast and gynecologic cancer patients who received chemotherapy between January 2020 and December 2023 were enrolled from our hospital. Blood samples were taken before chemotherapy, within 3 days after chemotherapy, and before the next course of chemotherapy. The level of plasma DAO and D-lactate were measured by enzyme-linked immunosorbent assay (ELISA) . After chemotherapy, nutritional markers such as albumin (ALB) and prealbumin (PAB) were evaluated. Anorexia, vomiting, nausea and diarrhea were evaluated during the chemotherapy cycle. There were no notable differences in serum DAO and D-lactate levels before chemotherapy among different tumor types, tumor stage and chemotherapy type. Serum DAO and D-lactate levels after chemotherapy were significantly elevated compared to their levels before chemotherapy (P \u003C .05) . The plasma DAO and D-lactate levels in cancer patients before the next course of chemotherapy were higher than those observed before the initial treatment, but the difference failed to achieve statistical significance (P > .05) . The levels of DAO before chemotherapy were higher in patients with diarrhea and anorexia after chemotherapy than those without diarrhea and anorexia (P \u003C .05) . The levels of D-lactate before chemotherapy were notably elevated in patients with vomiting, diarrhea and nausea after chemotherapy than those without vomiting, diarrhea and nausea (P \u003C .05) . Monitoring serum levels of DAO and D-lactate in cancer patients undergoing chemotherapy can serve as indicators for evaluating gastrointestinal dysfunction and nutritional status. |\n| --- |\n| Abbreviations: ALB = albumin, DAO = diamine oxidase, ELISA = enzyme-linked immunosorbent assay, PAB = prealbumin, SD = standard deviation. |\n| Keywords: cancer, chemotherapy, diamine oxidase, D-lactate |\n\n1. Introduction  \nCancers of the breast and female reproductive system, such as cervical, endometrial, ovarian, and other rare gynecologic malignancies, pose a significant threat to women’s health.[1] While surgical intervention is the primary treatment for early-stage cancers, chemotherapy is commonly employed for managing advanced or recurrent cases. Chemotherapy can substantially improve the prognosis of cancer patients, but it also carries the risk of serious side effects. Gastrointestinal toxicities resulting from chemotherapy can adversely impact patients’ nutritional status by reducing food intake and may lead to delays or discontinuation of treatment.  \nThe intact intestinal mucosal structure and normal intestinal barrier function are very important to improve the prognosis and prognosis of the patients with malignant tumor, this has also become an important factor affecting the process of chemotherapy. External stimuli can impair the normal  \nintestinal structure and enhance gut barrier permeability, allowing metabolites from the gut microbiota to leak into the bloodstream. [2] Alterations in serum diamine oxidase (DAO) and D-lactate levels may represent markers of changes in gut wall permeability.  \nDAO is an enzyme predominantly located in the gastrointestinal tract, where it is essential for metabolizing dietary histamine. When the intestinal barrier is compromised, DAO is transferred into the bloodstream, making serum DAO activity an indirect indicator of intestinal permeability.[3] Additionally, D-lactate is frequently utilized as an indicator for clinical assessment of intestinal mucosal permeability. D-lactate is an important metabolite in the digestive system, and its presence in the blood can indi","cbCaibUA6QCOXp1A","https://ap.wps.com/l/cbCaibUA6QCOXp1A","pdf",469276,"English","# Abstract\n# Introduction\n## Rationale and background\n# Methods\n## Study participants","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To evaluate changes in serum/plasma diamine oxidase (DAO) and D-lactate after chemotherapy and assess their clinical significance for intestinal barrier function, gastrointestinal dysfunction, and nutritional status.\"},{\"question\":\"How were DAO and D-lactate measured, and when were blood samples collected?\",\"answer\":\"Plasma DAO and D-lactate levels were measured by ELISA. Blood was collected before chemotherapy, within 3 days after chemotherapy, and before the next chemotherapy course.\"},{\"question\":\"What did the study find about DAO and D-lactate after chemotherapy?\",\"answer\":\"After chemotherapy, serum DAO and D-lactate levels were significantly higher than pre-chemotherapy levels (P \\u003c .05). Levels before the next course were higher than baseline but did not reach statistical significance (P \\u003e .05).\"},{\"question\":\"How did DAO and D-lactate relate to chemotherapy-related gastrointestinal symptoms and nutrition?\",\"answer\":\"Higher DAO before chemotherapy was observed in patients who developed diarrhea and anorexia after chemotherapy, and higher D-lactate was seen in those who developed vomiting, diarrhea, and nausea. The study also assessed nutritional markers (ALB and PAB) and suggests monitoring DAO/D-lactate to reflect gastrointestinal dysfunction and nutritional status.\"}]","Changes of diamine oxidase and D-lactate in human breast and gynecologic cancers after chemotherapy | PDF",[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65ba59050235395d9a0778659e32a080.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da72158b87de1c8d9bdae9d8e20dfefc.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b80cf41fddcd81faa1a81d79e26ed58.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d92c32d6ccf021aedbcc1392f0eaacfb.webp",980,1306]